Amedeo Smart

Free Medical Literature Service

 

Amedeo

Malignant Lymphoma
  Free Subscription

Articles published in
Int J Cancer
    May 2024
  1. FEDELI U, Barbiellini Amidei C, Han X, Jemal A, et al
    Changes in mortality associated with different hematologic malignancies during the pandemic in the United States.
    Int J Cancer. 2024;154:1703-1708.
    >> Share

    March 2024
  2. WANG X, Deng L, Ping L, Shi Y, et al
    Germline variants of DNA repair and immune genes in lymphoma from lymphoma-cancer families.
    Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34892.
    >> Share

  3. TABORELLI M, Serraino D, Cimaglia C, Furian L, et al
    Cancer mortality after kidney transplantation: A multicenter cohort study in Italy.
    Int J Cancer. 2024;154:842-851.
    >> Share

    December 2023
  4. LUO J, Hendryx M, Rohan TE, Saquib N, et al
    Hysterectomy, oophorectomy and risk of non-Hodgkin's lymphoma.
    Int J Cancer. 2023 Dec 19. doi: 10.1002/ijc.34820.
    >> Share

    October 2023
  5. DU Y, Wang Y, Li Q, Chang X, et al
    Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population-based study.
    Int J Cancer. 2023 Oct 24. doi: 10.1002/ijc.34773.
    >> Share

    September 2023
  6. WANG F, Palmer N, Fox K, Liao KP, et al
    Large-scale real-world data analyses of cancer risks among patients with rheumatoid arthritis.
    Int J Cancer. 2023;153:1139-1150.
    >> Share

  7. LINDMARK G, Olsson L, Sitohy B, Israelsson A, et al
    qRT-PCR analysis of CEACAM5, KLK6, SLC35D3, MUC2 and POSTN in colon cancer lymph nodes-An improved method for assessment of tumor stage and prognosis.
    Int J Cancer. 2023 Sep 12. doi: 10.1002/ijc.34718.
    >> Share

  8. MANGIATERRA TS, De Dios Soler M, Oviedo N, Colli S, et al
    Presence of EBV antigens detected by a sensitive method in pediatric and adult Diffuse Large B-cell lymphomas.
    Int J Cancer. 2023;153:1043-1050.
    >> Share

  9. SIRIRUNGREUNG A, Hansen J, Ritz B, Heck JE, et al
    Association between medically diagnosed postnatal infection and childhood cancers: A matched case-control study in Denmark, 1978 to 2016.
    Int J Cancer. 2023;153:994-1002.
    >> Share

    August 2023
  10. WEI YC, Qi F, Zheng BM, Zhang CG, et al
    Intensive therapy can improve long-term survival in newly diagnosed, advanced-stage extranodal NK/T-cell lymphoma: A multi-institutional, real-world study.
    Int J Cancer. 2023 Aug 4. doi: 10.1002/ijc.34672.
    >> Share

    June 2023
  11. ZENG D, Fang Y, Fei Y, Liang R, et al
    Treatment patterns and clinical outcomes of mantle cell lymphoma: a retrospective cohort study by CHOICE.
    Int J Cancer. 2023 Jun 6. doi: 10.1002/ijc.34619.
    >> Share

  12. MBURU W, Devesa SS, Check D, Shiels MS, et al
    Incidence of Burkitt lymphoma in the United States during 2000 to 2019.
    Int J Cancer. 2023 Jun 6. doi: 10.1002/ijc.34618.
    >> Share

  13. XIAO H, Wang S, Tang Y, Li S, et al
    Absence of terminal deoxynucleotidyl transferase expression in T-ALL/LBL accumulates chromosomal abnormalities to induce drug resistance.
    Int J Cancer. 2023;152:2383-2395.
    >> Share

    May 2023
  14. ZENG D, Fang Y, Fei Y, Liang R, et al
    Treatment patterns and clinical outcomes of mantle cell lymphoma: A retrospective cohort study by CHOICE.
    Int J Cancer. 2023 May 19. doi: 10.1002/ijc.34565.
    >> Share

  15. CHOLUJOVA D, Beke G, Hunter ZR, Hideshima T, et al
    Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenstrom macroglobulinemia.
    Int J Cancer. 2023;152:1947-1963.
    >> Share

    April 2023
  16. ENTROP JP, Weibull CE, Smedby KE, Jakobsen LH, et al
    Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study.
    Int J Cancer. 2023 Apr 29. doi: 10.1002/ijc.34552.
    >> Share

    December 2022
  17. KOTCHETKOV R, Drennan IR, Susman D, DiMaria E, et al
    Bendamustine and rituximab is well-tolerated and efficient in the treatment of indolent non-Hodgkin's lymphoma and Mantle Cell Lymphoma in elderly: A single center observational study.
    Int J Cancer. 2022 Dec 22. doi: 10.1002/ijc.34412.
    >> Share

    November 2022
  18. WANG Z, Phillips LS, Rohan TE, Ho GY, et al
    Diabetes, Metformin Use, and Risk of Non-Hodgkin's Lymphoma in Postmenopausal Women: A Prospective Cohort Analysis in the Women's Health Initiative.
    Int J Cancer. 2022 Nov 28. doi: 10.1002/ijc.34376.
    >> Share

    September 2022
  19. RHEE J, Birmann BM, De Roos AJ, Epstein MM, et al
    Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: a pooled analysis.
    Int J Cancer. 2022 Sep 24. doi: 10.1002/ijc.34299.
    >> Share

  20. ELVERDI T, Hiyamli MF, Sahin B, Eskazan AE, et al
    A new dawn for upfront autologous SCT in NK/T-cell lymphomas: One more step forward in reasoning.
    Int J Cancer. 2022;151:661-664.
    >> Share

    August 2022
  21. BOYLE T, Kleinstern G, Bracci PM, Cerhan JR, et al
    Physical activity and the risk of non-Hodgkin lymphoma subtypes: a pooled analysis.
    Int J Cancer. 2022 Aug 27. doi: 10.1002/ijc.34266.
    >> Share

    June 2022
  22. YARMOLINSKY J, Amos CI, Hung RJ, Moreno V, et al
    Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma risk.
    Int J Cancer. 2022 Jun 23. doi: 10.1002/ijc.34180.
    >> Share

  23. MAFRA A, Laversanne M, Gospodarowicz M, Klinger P, et al
    Global patterns of non-Hodgkin lymphoma in 2020.
    Int J Cancer. 2022 Jun 13. doi: 10.1002/ijc.34163.
    >> Share

    April 2022
  24. ABRAHAO R, Cooley JJP, Maguire FB, Parikh-Patel A, et al
    Stage at diagnosis and survival among adolescents and young adults with lymphomas following the Affordable Care Act implementation in California.
    Int J Cancer. 2022;150:1113-1122.
    >> Share

    January 2022
  25. SINGH D, Vaccarella S, Gini A, Silva NP, et al
    Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040.
    Int J Cancer. 2022 Jan 26. doi: 10.1002/ijc.33948.
    >> Share

    December 2021
  26. YOSHIDA-SAKAI N, Watanabe T, Yamamoto Y, Ureshino H, et al
    Adult T-cell leukemia-lymphoma acquires resistance to DNA demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism.
    Int J Cancer. 2021 Dec 16. doi: 10.1002/ijc.33901.
    >> Share

  27. JI J, Liu Z, Kuang P, Dong T, et al
    A new conditioning regimen with chidamide, cladribine, gemcitabine and busulfan significantly improve the outcome of high-risk or relapsed/refractory non-Hodgkin's lymphomas.
    Int J Cancer. 2021;149:2075-2082.
    >> Share

  28. FOUNTZILAS C, Adjei A, Opyrchal M, Evans R, et al
    A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine-based chemotherapy in patients with advanced solid tumors.
    Int J Cancer. 2021;149:2063-2074.
    >> Share

    October 2021
  29. WU J, Song Y, Chen X, Lin T, et al
    Camrelizumab for relapsed or refractory classical Hodgkin lymphoma: extended follow-up of the multicenter, single-arm, phase 2 study.
    Int J Cancer. 2021 Oct 21. doi: 10.1002/ijc.33852.
    >> Share

  30. MPUNGA T, Clifford GM, Morgan EA, Milner DA Jr, et al
    Epstein-Barr virus prevalence among subtypes of malignant lymphoma in Rwanda, 2012-2018.
    Int J Cancer. 2021 Oct 9. doi: 10.1002/ijc.33840.
    >> Share

    September 2021
  31. SHEN Z, Hu L, Yao M, He C, et al
    Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and EBER status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group.
    Int J Cancer. 2021 Sep 14. doi: 10.1002/ijc.33802.
    >> Share

    July 2021
  32. DE ROOS AJ, Schinasi LH, Miligi L, Cerhan JR, et al
    Occupational Insecticide Exposure and Risk of Non-Hodgkin Lymphoma: A Pooled Case-Control Study from the InterLymph Consortium.
    Int J Cancer. 2021 Jul 16. doi: 10.1002/ijc.33740.
    >> Share

    June 2021
  33. HERDA S, Heimann A, Obermayer B, Ciraolo E, et al
    Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challenges.
    Int J Cancer. 2021;148:3097-3110.
    >> Share

  34. JAQUET A, Boni SP, Boidy K, Tine J, et al
    Chronic viral hepatitis, HIV infection and Non-Hodgkin lymphomas in West Africa, a case-control study.
    Int J Cancer. 2021 Jun 14. doi: 10.1002/ijc.33709.
    >> Share

  35. PARKIN DM, Youlden DR, Chitsike I, Chokunonga E, et al
    Stage at diagnosis and survival by stage for the leading childhood cancers in three populations of sub-Saharan Africa.
    Int J Cancer. 2021;148:2685-2691.
    >> Share

    April 2021
  36. SHI Z, Wei J, Na R, Resurreccion WK, et al
    Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank.
    Int J Cancer. 2021;148:1658-1664.
    >> Share

  37. SOLIMAN RM, Elhaddad A, Oke J, Eweida W, et al
    Temporal trends in childhood cancer survival in Egypt, 2007 to 2017: A large retrospective study of 14 808 children with cancer from the Children's Cancer Hospital Egypt.
    Int J Cancer. 2021;148:1562-1574.
    >> Share

    March 2021
  38. GAUT D, Tang K, Sim MS, Duong T, et al
    Filgrastim associations with CAR T-cell therapy.
    Int J Cancer. 2021;148:1192-1196.
    >> Share

    November 2020
  39. JIANG S, Qin Y, Jiang H, Liu B, et al
    Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroup.
    Int J Cancer. 2020;147:2611-2620.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016